Caplight Directory>Companies>Nurture Genomics-preview>Nurturegenomics


Nurture Genomics

Nurture Genomics

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://nurturegenomics.com/

Last Round

SAFE

Aug 8, 2023

Total Funding Raised

$3.41M

Momentum Score

25 /100

Company Overview

Nurture Genomics is a healthcare services company that provides genetic testing services intended for newborns and children. The company offers comprehensive genome sequencing that analyzes genes associated with potential childhood-onset genetic conditions, enabling parents and pediatricians to get actionable results and virtual consultations from genetic counselors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, D2C Brands, Telemedicine, Medical AI

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

newborn genetic screeningwhole genome sequencingdirect-to-consumer genetic testingDTC genetic testingpediatric genetic testingbaby DNA testgenetic counselingexpanded newborn screeningat-home collection kitproactive genetic testingchildhood-onset conditionscare navigationWGShealth system partnershipsprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nurture Genomics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nurture Genomics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SAFEAug 8, 2023
Early FundingApr 20, 2023
View all Funding Rounds

Nurture Genomics Investors

Notable investors and investment history

InvestorRounds
HealthTech CapitalSAFE, Early Funding
Bantam GroupSAFE
The Charles Hood FoundationSAFE
ImpactAssetsSAFE, Early Funding
View all Investors

Nurture Genomics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nurture Genomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nurture Genomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range20
Year Founded2022
Last FundingAug 8, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.